5/14/2012 – “Cyclacel Announces Completion of Enrollment in Investigator-Initiated, Phase 2/3 Randomized Trial Comparing Sapacitabine to Low Dose Cytarabine” press release
5/7/2012 – “Idera Pharmaceuticals Announces Efficacy Data for IMO-8400 in Preclinical Models of Lupus and Psoriasis” press release
4/17/2012 – “New Phase 2 Data From Brain Cancer Study With Agenus’ Prophage Vaccine (HSPPC-96) Presented at Plenary Session of AANS” press release
4/16/2012 – “Bavarian Nordic A/S – Report on the Results of the Annual General Meeting, held 16 April 2012″ press release
3/5/2012 – “Agenus Expands QS-21 License and Grants Right of First Negotiation to GlaxoSmithKline” press release
3/1/2012 – “Bavarian Nordic Submits a Marketing Application for its Smallpox Vaccine to the European Medicines Agency” press release
2/13/2012 – “Cyclacel Provides Update on Clinical Progress With Sapacitabine as Second Line Therapy in Older Patients With Myelodysplastic Syndromes” press release
